SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

MCKILLIGAN RICHARD

(Last)

(First)

(Middle)

200 PARK AVENUE,

SUITE 400

(Street)

CLEVELAND,

44122

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
MALACHITE INNOVATIONS, INC. [ MLCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2021

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$2.7	12/10/2021⁽⁵⁾		D			10,000	08/06/2012⁽¹⁾	08/06/2022	Common Stock	10,000	$0.00	0	D
Stock Option (Right to Buy)	$3.4	12/10/2021⁽⁵⁾		D			20,000	01/01/2015⁽²⁾	01/01/2025	Common Stock	20,000	$0.00	0	D
Stock Option (Right to Buy)	$2.1	12/10/2021⁽⁵⁾		D			20,000	05/21/2015⁽³⁾	05/21/2025	Common Stock	20,000	$0.00	0	D
Stock Option (Right to Buy)	$1.81	12/10/2021⁽⁵⁾		D			75,000	12/21/2017⁽⁴⁾	12/21/2027	Common Stock	75,000	$0.00	0	D
Stock Option (Right to Buy)	$0.277	12/10/2021		A		114,769		12/10/2021⁽⁵⁾	12/10/2031	Common Stock	114,769	$0.00	114,769	D
Stock Option (Right to Buy)	$0.277	12/10/2021		A		35,231		12/10/2021⁽⁶⁾	12/10/2031	Common Stock	35,231	$0.00	150,000	D

Explanation of Responses:

1. An option to purchase 10,000 shares of common stock was granted to the Reporting Person on 8/6/12, 3,333 shares vested on 1/1/13 and 1/1/14, and 3,334 shares vested on 1/1/15.

2. The option provided for vesting in four equal semi-annual installments beginning on 7/1/15.

3. The option provided for vesting in four equal semi-annual installments beginning on 11/21/15.

4. The option provided for vesting in four equal semi-annual installments beginning on 6/27/18.

5. On December 10, 2021, the issuer canceled, this option pursuant to the issuer's option exchange program, the options listed above. In exchange, the Reporting Person received a replacement option to purchase 114,769 shares at an exercise price of $0.277. This replacement option vested immediately.

6. On December 10, 2021, the Reporting Person was granted options to purchase 35,231 shares of common stock at an exercise price of $0.277. This option vested immediately.

	/s/ Richard McKilligan	12/10/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.